Selective serotonin re-uptake inhibitors
เชิงอรรถและอ้างอิง

↑  Barlow, David H; Durand, V. Mark (2009). "Chapter 7: Mood Disorders and Suicide". Abnormal Psychology: An Integrative Approach (Fifth ed.). Belmont, CA: Wadsworth Cengage Learning. p. 239. ISBN 0-495-09556-7. OCLC 192055408.{{cite book}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  "Prozac" (PDF). Lilly and Company. p. 20.
↑  Preskorn, SH; Ross, R; Stanga, CY (2004). "Selective Serotonin Reuptake Inhibitors".  ใน Sheldon H. Preskorn; Hohn P. Feighner; Christina Y. Stanga; Ruth Ross (บ.ก.). Antidepressants: Past, Present and Future. Berlin: Springer. pp. 241–62. ISBN 978-3-540-43054-4.{{cite book}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (January 2010). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Kramer, Peter (7 September 2011). "In Defense of Antidepressants". The New York Times. สืบค้นเมื่อ 13 July 2011.
↑  
Pies, R (April 2010). "Antidepressants Work, Sort of-Our System of Care Does Not". Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
↑  Medford, Nick. "Understanding and treating depersonalization disorder". Advances in Psychiatric Treatment (2005). สืบค้นเมื่อ 11 November 2011.
1 2  "www.nice.org.uk" (PDF). NICE. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 28 September 2013. สืบค้นเมื่อ 1 September 2016.
1 2  Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (February 2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Horder, J; Matthews, P; Waldmann, R (June 2010). "Placebo, Prozac and PLoS: significant lessons for psychopharmacology". Journal of Psychopharmacology (Oxford, England). 25 (10): 1277–88. doi:10.1177/0269881110372544. PMID 20571143.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Fountoulakis, KN; Möller, HJ (August 2010). "Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data". The International Journal of Neuropsychopharmacology. 14 (3): 1–8. doi:10.1017/S1461145710000957. PMID 20800012.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Depression: The NICE Guideline on the Treatment and Management of Depression in Adults (Updated Edition) (PDF). RCPsych Publications. 2010. ISBN 1-904671-85-3.
↑  Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (January 2010). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Gartlehner, G; Hansen, RA; Morgan, LC; Thaler, K; Lux, L; Van Noord, M; Mager, U; Thieda, P; Gaynes, BN; Wilkins, T; Strobelberger, M; Lloyd, S; Reichenpfader, U; Lohr, KN (December 2011). "Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis". Annals of Internal Medicine. 155 (11): 772–85. doi:10.7326/0003-4819-155-11-201112060-00009. PMID 22147715.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Hetrick, SE; McKenzie, JE; Cox, GR; Simmons, MB; Merry, SN (14 November 2012). "Newer generation antidepressants for depressive disorders in children and adolescents". The Cochrane Database of Systematic Reviews. 11: CD004851. doi:10.1002/14651858.cd004851.pub3. PMID 23152227.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  "Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults" (PDF). NICE. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 21 October 2012. สืบค้นเมื่อ 20 February 2013.
1 2  Kapczinski, F; Lima, MS; Souza, JS; Schmitt, R (2003).  Kapczinski, Flavio FK (บ.ก.). "Antidepressants for generalized anxiety disorder". The Cochrane Database of Systematic Reviews (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.{{cite journal}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  "Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder" (PDF). November 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 6 December 2008. สืบค้นเมื่อ 1 September 2016.
↑  
Arroll, B; Elley, CR; Fishman, T; Goodyear-Smith, FA; Kenealy, T; Blashki, G; Kerse, N; Macgillivray, S (2009).  Arroll, Bruce (บ.ก.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews (3): CD007954. doi:10.1002/14651858.CD007954. PMID 19588448.{{cite journal}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  "Medscape Log In". เก็บจากแหล่งเดิมเมื่อ 13 April 2013. สืบค้นเมื่อ 1 September 2016.
↑  รองศาสตราจารย์ ดร.ประตาป สิงหศิวานนท์, ผู้ช่วยศาสตราจารย์ ดร.จรณิต แก้วกังวาล (2554).  ศาสตราจารย์แพทย์หญิงพรรณี ปิติสุทธิธรรม, รองศาสตราจารย์ ดร.ชยันต์ พิเชียรสุนทร (บ.ก.). "บทที่ 2 รูปแบบการวิจัยทางคลินิก" (PDF). ตำราการวิจัยทางคลินิก (Textbook of Clinical Research). มหาวิทยาลัยมหิดล. p. 49-51. ISBN 978-974-11-1462-7. เก็บ (PDF)จากแหล่งเดิมเมื่อ 7 July 2015. สืบค้นเมื่อ 22 September 2016.
↑  
Fineberg, NA; Brown, A; Reghunandanan, S; Pampaloni, I (2012). "Evidence-based pharmacotherapy of obsessive-compulsive disorder". The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. PMID 22226028.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
"Sertraline prescribing information" (PDF). FDA. สืบค้นเมื่อ 2015-01-30.
↑  
"Paroxetine prescribing information" (PDF). Apotex. สืบค้นเมื่อ 2015-01-30.
1 2 3  "Eating disorders in over 8s: management" (PDF). NICE. January 2004.
1 2  "National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 25 May 2013. สืบค้นเมื่อ 1 September 2016.
↑  Flament, MF; Bissada, H; Spettigue, W (March 2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Mead, GE; Hsieh, CF; Lee, R; Kutlubaev, MA; Claxton, A; Hankey, GJ; Hackett, ML (2012).  Mead, Gillian E (บ.ก.). "Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery". The Cochrane Database of Systematic Reviews. 11: CD009286. doi:10.1002/14651858.CD009286.pub2. PMID 23152272.{{cite journal}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  Waldinger, MD (November 2007). "Premature ejaculation: state of the art". The Urologic Clinics of North America. 34 (4): 591–9, vii–viii. doi:10.1016/j.ucl.2007.08.011. PMID 17983899.
↑  Wu, Q; Bencaz, AF; Hentz, JG; Crowell, MD (January 2012). "Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies". Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 23 (1): 365–75. doi:10.1007/s00198-011-1778-8. PMID 21904950.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Stahl, SM; Lonnen, AJ (2011). "The Mechanism of Drug-induced Akathsia". CNS Spectrums. PMID 21406165.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Lane, RM (1998). "SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment". Journal of Psychopharmacology (Oxford, England). 12 (2): 192–214. doi:10.1177/026988119801200212. PMID 9694033.
↑  
Koliscak, LP; Makela, EH (2009). "Selective serotonin reuptake inhibitor-induced akathisia". Journal of the American Pharmacists Association : JAPhA. 49 (2): e28-36, quiz e37-8. doi:10.1331/JAPhA.2009.08083. PMID 19289334.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Leo, RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of Clinical Psychiatry. 57 (10): 449–54. doi:10.4088/JCP.v57n1002. PMID 8909330.
↑  "SSRIs and Depression". Emedicinehealth.com. 23 September 2012. สืบค้นเมื่อ 23 September 2012.
1 2  Bahrick, Audrey (2008). "Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence" (PDF). The Open Psychology Journal. 1: 42–50. doi:10.2174/1874350100801010042. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 19 October 2013. สืบค้นเมื่อ 2014-01-30.
↑  Taylor, MJ; Rudkin, L; Bullemor-Day, P; Lubin, J; Chukwujekwu, C; Hawton, K (31 May 2013). "Strategies for managing sexual dysfunction induced by antidepressant medication". The Cochrane database of systematic reviews. 5: CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
↑  Kennedy, SH; Rizvi, S (April 2009). "Sexual dysfunction, depression, and the impact of antidepressants". Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977.
↑  
Waldinger, MD (2015). "Psychiatric disorders and sexual dysfunction". Handbook of clinical neurology / edited by David B. Vodušek and François Boller. Handbook of Clinical Neurology. 130: 469–89. doi:10.1016/B978-0-444-63247-0.00027-4. ISBN 9780444632470. PMID 26003261.
↑  
"Prozac" (PDF). Lilly and Company. p. 14.
↑  
"One hundred and twenty cases of enduring sexual dysfunction following treatment". ResearchGate. doi:10.3233/JRS-140617. สืบค้นเมื่อ 2016-01-30.
↑  Gitlin, M. J. (1 September 1994). "Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches". The Journal of Clinical Psychiatry. 55 (9): 406–413. ISSN 0160-6689. PMID 7929021.
↑  "Antidepressant-Associated Sexual Dysfunction: A Potentially Avoidable Therapeutic Challenge - Primary Psychiatry". Primary Psychiatry (ภาษาอังกฤษแบบอเมริกัน). สืบค้นเมื่อ 2016-01-30.
↑  
Clayton, Anita H. (2003). "Antidepressant-Associated Sexual Dysfunction: A Potentially Avoidable Therapeutic Challenge". Primary Psychiatry. 10 (1): 55–61.
↑  
Kanaly, KA; Berman, JR (December 2002). "Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction". Current Women's Health Reports. 2 (6): 409–16. PMID 12429073.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Balon, R (2006). "SSRI-Associated Sexual Dysfunction". The American Journal of Psychiatry. 163 (9): 1504–9, quiz 1664. doi:10.1176/appi.ajp.163.9.1504. PMID 16946173.
↑  Koyuncu, H; Serefoglu, EC; Ozdemir, AT; Hellstrom, WJ (September 2012). "Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation". Int. J. Impot. Res. 24 (5): 171–3. doi:10.1038/ijir.2012.12. PMID 22573230.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Oh, SW; Kim, J; Myung, SK; Hwang, SS; Yoon, DH (20 March 2014). "Antidepressant Use and Risk of Coronary Heart Disease: Meta-Analysis of Observational Studies". British Journal of Clinical Pharmacology. 78 (4): 727–37. doi:10.1111/bcp.12383. PMID 24646010.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Huybrechts, KF; Palmsten, K; Avorn, J; Cohen, LS; Holmes, LB; Franklin, JM; Mogun, H; Levin, R; Kowal, M; Setoguchi, S; Hernández-Díaz, S (2014). "Antidepressant Use in Pregnancy and the Risk of Cardiac Defects". New England Journal of Medicine. 370 (25): 2397–2407. doi:10.1056/NEJMoa1312828. ISSN 0028-4793. PMID 24941178.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Goldberg, RJ (1998). "Selective serotonin reuptake inhibitors: infrequent medical adverse effects". Archives of Family Medicine. 7 (1): 78–84. doi:10.1001/archfami.7.1.78. PMID 9443704. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 23 June 2011. สืบค้นเมื่อ 1 September 2016.
↑  
"FDA Drug Safety". FDA.
↑  
"Citalopram and escitalopram: QT interval prolongation—new maximum daily dose restrictions (including in elderly patients), contraindications, and warnings". Medicines and Healthcare Products Regulatory Agency. December 2011.
↑  
"ref2" (PDF). สืบค้นเมื่อ 23 September 2012.
↑  Pacher, P; Ungvari, Z; Nanasi, PP; Furst, S; Kecskemeti, V (June 1999). "Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?". Current medicinal chemistry. 6 (6): 469–80. PMID 10213794.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Weinrieb, RM; Auriacombe, M; Lynch, KG; Lewis, JD (March 2005). "Selective serotonin re-uptake inhibitors and the risk of bleeding". Expert Opinion on Drug Safety. 4 (2): 337–44. doi:10.1517/14740338.4.2.337. PMID 15794724.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Taylor, D; Carol, P; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 9780470979693.
↑  
Andrade, C; Sandarsh, S; Chethan, KB; Nagesh, KS (December 2010). "Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–1575. doi:10.4088/JCP.09r05786blu. PMID 21190637.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
de Abajo, FJ; García-Rodríguez, LA (July 2008). "Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents". Archives of General Psychiatry. 65 (7): 795–803. doi:10.1001/archpsyc.65.7.795. PMID 18606952.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Hackam, DG; Mrkobrada, M (2012). "Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis". Neurology. 79 (18): 1862–5. doi:10.1212/WNL.0b013e318271f848. PMID 23077009.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Serebruany, VL (February 2006). "Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?". The American Journal of Medicine. 119 (2): 113–6. doi:10.1016/j.amjmed.2005.03.044. PMID 16443409.
↑  
Halperin, D; Reber, G (2007). "Influence of antidepressants on hemostasis". Dialogues in Clinical Neuroscience. 9 (1): 47–59. PMC 3181838. PMID 17506225.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Andrade, C; Sandarsh, S; Chethan, KB; Nagesh, KS (2010). "Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–75. doi:10.4088/JCP.09r05786blu. PMID 21190637.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
de Abajo, FJ (2011). "Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients". Drugs & Aging. 28 (5): 345–67. doi:10.2165/11589340-000000000-00000. PMID 21542658.
1 2  "PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder," (3rd ed.). คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 19 February 2014. สืบค้นเมื่อ 1 September 2016.
↑  
Renoir, T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Frontiers in Pharmacology. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
1 2  
Stone, MB; Jones, ML (17 November 2006). "Clinical review: relationship between antidepressant drugs and suicidal behavior in adults" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. pp. 11–74. สืบค้นเมื่อ 22 September 2007.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Levenson, M; Holland, C (17 November 2006). "Statistical Evaluation of Suicidality in Adults Treated with Antidepressants" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. pp. 75–140. สืบค้นเมื่อ 22 September 2007.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Olfson, M; Marcus, SC; Shaffer, D (August 2006). "Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study". Archives of General Psychiatry. 63 (8): 865–72. doi:10.1001/archpsyc.63.8.865. PMID 16894062.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Hammad, TA (16 August 2004). "Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidal behavior" (PDF). FDA. pp. 42, 115. สืบค้นเมื่อ 29 May 2008.
↑  
"Antidepressant Use in Children, Adolescents, and Adults". FDA.
↑  
"FDA Medication Guide for Antidepressants" (PDF). สืบค้นเมื่อ 5 June 2014.
↑  
update version Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Depression in adults: recognition and Depression in adults: recognition and management management (CG90)". NICE. 28 October 2009. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 3 November 2015. สืบค้นเมื่อ 1 September 2016.
↑  Update version Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  doi:10.1089/cap.2006.0138
This citation will be automatically completed in the next few minutes. You can jump the queue or
↑  Gibbons, RD; Hur, K; Bhaumik, DK; Mann, JJ (November 2006). "The relationship between antidepressant prescription rates and rate of early adolescent suicide". The American Journal of Psychiatry. 163 (11): 1898–904. doi:10.1176/appi.ajp.163.11.1898. PMID 17074941.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants" (PDF). Medicines and Healthcare products Regulatory Agency. 1 December 2004. สืบค้นเมื่อ 25 September 2007.
↑  "Selective Serotonin Reuptake Inhibitors (SSRIs) : Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data". Medicines and Healthcare products Regulatory Agency. 29 September 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 5 December 2014. สืบค้นเมื่อ 29 May 2008.
↑  Gunnell, D; Saperia, J; Ashby, D (February 2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". BMJ (Clinical Research ed.). 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMC 549105. PMID 15718537.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Fergusson, D; Doucette, S; Glass, KC; Shapiro, S; Healy, D; Hebert, P; Hutton, B (February 2005). "Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials". BMJ (Clinical Research Ed.). 330 (7488): 396. doi:10.1136/bmj.330.7488.396. PMC 549110. PMID 15718539.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Rihmer, Z; Akiskal, H (August 2006). "Do antidepressants t(h) reat (en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries". Journal of Affective Disorders. 94 (1–3): 3–13. doi:10.1016/j.jad.2006.04.003. PMID 16712945.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Hall, WD; Lucke, J (2006). "How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?". The Australian and New Zealand Journal of Psychiatry. 40 (11–12): 941–50. doi:10.1111/j.1440-1614.2006.01917.x. PMID 17054562.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Malm, H (December 2012). "Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome". Therapeutic Drug Monitoring. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258.
↑  
Rahimi, R; Nikfar, S; Abdollahi, M (2006). "Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials". Reproductive Toxicology (Elmsford, N.Y.). 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Nikfar, S; Rahimi, R; Hendoiee, N; Abdollahi, M (2012). "Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis". Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  doi:10.1176/appi.ajp.2015.14121575
This citation will be automatically completed in the next few minutes. You can jump the queue or  Full ArticlePDF (556 KB)
↑  Einarson, TR; Kennedy, D; Einarson, A (2012). "Do findings differ across research design? The case of antidepressant use in pregnancy and malformations". Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Thérapeutique Des Populations Et De La Pharamcologie Clinique. 19 (2): e334-48. PMID 22946124.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Riggin, L; Frankel, Z; Moretti, M; Pupco, A; Koren, G (April 2013). "The fetal safety of fluoxetine: a systematic review and meta-analysis". Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC. 35 (4): 362–9. PMID 23660045.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Koren, G; Nordeng, HM (February 2013). "Selective serotonin reuptake inhibitors and malformations: case closed?". Seminars in Fetal & Neonatal Medicine. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Breastfeeding Update: SDCBC's quarterly newsletter". Breastfeeding.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 25 February 2009. สืบค้นเมื่อ 10 July 2010.
↑  "Using Antidepressants in Breastfeeding Mothers". kellymom.com. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 23 September 2010. สืบค้นเมื่อ 10 July 2010.
↑  
Gentile, S; Rossi, A; Bellantuono, C (2007). "SSRIs during breastfeeding: spotlight on milk-to-plasma ratio". Archives of Women's Mental Health. 10 (2): 39–51. doi:10.1007/s00737-007-0173-0. PMID 17294355.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Fenger-Grøn, J; Thomsen, M; Andersen, KS; Nielsen, RG (September 2011). "Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review". Danish Medical Bulletin. 58 (9): A4303. PMID 21893008.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Kieviet, N; Dolman, KM; Honig, A (2013). "The use of psychotropic medication during pregnancy: how about the newborn?". Neuropsychiatric Disease and Treatment. 9: 1257–1266. doi:10.2147/NDT.S36394. PMC 3770341. PMID 24039427.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Persistent Newborn Pulmonary Hypertension". Medscape.
↑  Grigoriadis, S; Vonderporten, EH; Mamisashvili, L; Tomlinson, G; Dennis, CL; Koren, G; Steiner, M; Mousmanis, P; Cheung, A; Ross, LE (2014). "Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis". BMJ (Clinical Research Ed.). 348: f6932. doi:10.1136/bmj.f6932. PMC 3898424. PMID 24429387.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  GW, 't Jong; Einarson, T; Koren, G; Einarson, A (November 2012). "Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN) : a systematic review". Reproductive Toxicology (Elmsford, N.Y.). 34 (3): 293–7. doi:10.1016/j.reprotox.2012.04.015. PMID 22564982.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Gentile, S (2015). "Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?". J Affect Disord. 182: 132–7. doi:10.1016/j.jad.2015.04.048. PMID 25985383. Epub 2015 May 6.